Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2

COVID-19 has spread worldwide since 2019 and is now a severe threat to public health. We previously identified the causative agent as a novel SARS-related coronavirus (SARS-CoV-2) that uses human angiotensin-converting enzyme 2 (hACE2) as the entry receptor. Here, we successfully developed a SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ren-Di, Liu, Mei-Qin, Chen, Ying, Shan, Chao, Zhou, Yi-Wu, Shen, Xu-Rui, Li, Qian, Zhang, Lei, Zhu, Yan, Si, Hao-Rui, Wang, Qi, Min, Juan, Wang, Xi, Zhang, Wei, Li, Bei, Zhang, Hua-Jun, Baric, Ralph S., Zhou, Peng, Yang, Xing-Lou, Shi, Zheng-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241398/
https://www.ncbi.nlm.nih.gov/pubmed/32516571
http://dx.doi.org/10.1016/j.cell.2020.05.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241398/
https://www.ncbi.nlm.nih.gov/pubmed/32516571
http://dx.doi.org/10.1016/j.cell.2020.05.027

Ejemplares similares